Literature DB >> 28831668

Fish Collagen Hydrolysates Modulate Cartilage Metabolism.

Kanchanit Boonmaleerat1, Orawan Wanachewin2, Thanyaluck Phitak1, Peraphan Pothacharoen1, Prachya Kongtawelert3.   

Abstract

Osteoarthritis is a degenerative joint disease in which interleukin-1β plays a major role in the inflammatory process. Administration of collagen hydrolysate was an optional treatment of osteoarthritis. Fish has become an interesting source of collagen hydrolysate because of religious reason and there is no risk from mad cow disease. However, the effects of different sizes of fish collagen hydrolysate on cartilage and chondrocyte metabolism have not been well studied yet. This study examined the effect of different sizes of fish collagen hydrolysate on cartilage metabolism. Three different sizes of fish collagen hydrolysate were prepared by size exclusion using centrifugation, which composed of small fraction (<3 kDa), medium fraction (3-10 kDa) and large fraction (>10 kDa). Using porcine cartilage explant, in physiological condition, all the three fractions had no effect on cartilage metabolism, but they could induce pro-MMP3 and pro-MMP13 secretions through activation of p-ERK and p-p38. In pathological condition induced by interleukin-1β and oncostatin-M, small and medium fractions showed additive effect with interleukin-1β and oncostatin-M on cartilage degradation, whereas large size had no effect. In addition, the effect of small size occurred through further activation of p-p65, which resulted in further induction of active-MMP13, while medium size had a different mechanism. In conclusion, all three fractions fish collagen hydrolysate had no effect on cartilage metabolism in physiological condition, but small and medium fractions had adverse effect on cartilage in pathological condition. Taken together, various sizes of fish collagen hydrolysate showed different effects on cartilage metabolism. Therefore, different sizes of fish collagen hydrolysates play different roles on cartilage metabolism, especially in the pathological condition.

Entities:  

Keywords:  Cartilage explants; Chondrocyte; Fish collagen hydrolysate; IL-1β; OSM

Mesh:

Substances:

Year:  2017        PMID: 28831668     DOI: 10.1007/s12013-017-0817-2

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  6 in total

1.  Porous fish collagen for cartilage tissue engineering.

Authors:  Hao Li; Ru Chen; Zihao Jia; Cheng Wang; Yong Xu; Chengde Li; Huitang Xia; Depeng Meng
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

2.  An Observational 1-Month Trial on the Efficacy and Safety of Promerim for Improving Knee Joint.

Authors:  Bekir Eray Kilinc; Yunus Oc; Gungor Alibakan; Emre Bilgin; Muharrem Kanar; Osman Tugrul Eren
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2018-02-11

Review 3.  Role of Collagen Derivatives in Osteoarthritis and Cartilage Repair: A Systematic Scoping Review With Evidence Mapping.

Authors:  Germain Honvo; Laetitia Lengelé; Alexia Charles; Jean-Yves Reginster; Olivier Bruyère
Journal:  Rheumatol Ther       Date:  2020-10-17

Review 4.  A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?

Authors:  Ursule Kalvaityte; Ilona Uzieliene; Christina E Larder; Michèle M Iskandar; Ali Mobasheri; Armaghan Mahmoudian; Stan Kubow; Paulo Cesar Hamdan; Cyro Scala de Almeida; Lacey J Favazzo; Luc J C van Loon; Pieter J Emans; Pérola G Plapler; Michael J Zuscik
Journal:  Curr Rheumatol Rep       Date:  2021-10-30       Impact factor: 4.686

Review 5.  Developments for Collagen Hydrolysate in Biological, Biochemical, and Biomedical Domains: A Comprehensive Review.

Authors:  Muhammad Harris; Johan Potgieter; Kashif Ishfaq; Muhammad Shahzad
Journal:  Materials (Basel)       Date:  2021-05-25       Impact factor: 3.623

6.  High Throughput Identification of Antihypertensive Peptides from Fish Proteome Datasets.

Authors:  Yunhai Yi; Yunyun Lv; Lijun Zhang; Jian Yang; Qiong Shi
Journal:  Mar Drugs       Date:  2018-10-02       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.